MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1

Abstract EN

Background.

MicroRNAs (miRs) have been implicated in the development and progression of osteosarcoma.

Here, we aimed to illustrate the important role of miR-92a on the regulation of OS development which may help to establish a novel strategy for OS diagnosis and treatment.

Materials and Methods.

Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.

Cell cycle and apoptosis were assessed by flow cytometry with PI and PI/Annexin-V stain, respectively.

The expression of proteins was examined by western blot.

qPCR was used to detect the expression of RNA.

Cell migration was assayed with transwell assay.

Results.

MiR-92a inhibited the proliferation and the migration of OS in vitro and reduced the volume of the tumour in vivo.

Further, miR-92a enhanced cisplatin sensitivity of OS.

MiR-92a directly targeted Notch1.

Conclusion.

Together, our results indicate that miR-92a inhibited cell growth, migration, and enhanced cisplatin sensitivity of OS cell by targeting Notch1.